Effect of Neuromuscular Blockade on the Insertion of ProSeal™ Laryngeal Mask Airway and Postoperative Pharyngolaryngeal Discomfort
Overview
- Phase
- Not Applicable
- Intervention
- use of rocuronium when the LMA is inserted
- Conditions
- General Anesthesia
- Sponsor
- Seoul National University Bundang Hospital
- Enrollment
- 160
- Locations
- 1
- Primary Endpoint
- success rate and insertion time
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
The aim of this study is to evaluate the success rate, insertion time and complication depending on the use of neuromuscular blocking agent when inserting the laryngeal mask airway (LMA).
Investigators
Hyo-Seok Na
Dr.
Seoul National University Bundang Hospital
Eligibility Criteria
Inclusion Criteria
- •18-70 year
- •american society of anesthesiologist status 1-2
- •elective general anesthesia
Exclusion Criteria
- •known or predicted difficult airway
- •recent sore throat
- •mouth opening less than 2.5 cm
- •at risk of aspiration
Arms & Interventions
group N
Anesthesia is induced with propofol and remifentanil and LMA is inserted by the standard technique according to eht manufacturer's instruction. Rocuronium is administered for the operation.
Intervention: use of rocuronium when the LMA is inserted
group R
Anesthesia is induced with a propofol and remifentanil and rocuronium 0.06 mg/kg is injected. Insertion of LMA is performed by the standard technique according to the manufacturer's instruction.
Intervention: use of rocuronium when the LMA is inserted
Outcomes
Primary Outcomes
success rate and insertion time
Time Frame: when laryngeal mask airway is inserted
Secondary Outcomes
- complication after the remove of LMA - bleeding, sore throat(1 hour after the LMA is removed)